Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus.

about

Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus.

Item

http://www.wikidata.org/entity/Q55100613

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Characterisation of anifroluma ...... systemic lupus erythematosus.

@en

Characterisation of anifroluma ...... systemic lupus erythematosus.

@nl

type

Item

label

Characterisation of anifroluma ...... systemic lupus erythematosus.

@en

Characterisation of anifroluma ...... systemic lupus erythematosus.

@nl

prefLabel

Characterisation of anifroluma ...... systemic lupus erythematosus.

@en

Characterisation of anifroluma ...... systemic lupus erythematosus.

@nl

P1476

Characterisation of anifroluma ...... systemic lupus erythematosus.

@en

P2093

Bhargavi Rajan

http://www.w3.org/2001/XMLSchema#string

Chris Morehouse

http://www.w3.org/2001/XMLSchema#string

Divya Sagar

http://www.w3.org/2001/XMLSchema#string

Erika Farmer

http://www.w3.org/2001/XMLSchema#string

Gary P Sims

http://www.w3.org/2001/XMLSchema#string

Inna Vainshtein

http://www.w3.org/2001/XMLSchema#string

Jeffrey M Riggs

http://www.w3.org/2001/XMLSchema#string

Jodi L Karnell

http://www.w3.org/2001/XMLSchema#string

Kamelia Zerrouki

http://www.w3.org/2001/XMLSchema#string

Kevin Schifferli

http://www.w3.org/2001/XMLSchema#string

P2860

Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6

Regulation of type I interferon responses

Structural characterization of a human Fc fragment engineered for lack of effector functions

Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus

Mechanisms of type-I- and type-II-interferon-mediated signalling

Network analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosus

Two interferon-induced nuclear factors bind a single promoter element in interferon-stimulated genes.

Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy.

Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus.

Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model.

P304

e000261

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/LUPUS-2018-000261

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29644082

http://www.w3.org/2001/XMLSchema#string

P932

5890856

http://www.w3.org/2001/XMLSchema#string